Eicosanoid Inhibitors as Therapeutic Targets for Metabolic Syndrome Related Kidney Disease

By  

Current Enzyme Inhibition, Vol. 2, Iss. 1, 2006-02 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma

By Slominska Ewa M.   Rutkowski Przemyslaw   Smolenski Ryszard T.   Szutowicz Andrzej   Rutkowski Boleslaw   Swierczynski Julian  

Molecular and Cellular Biochemistry, Vol. 267, Iss. 1-2, 2004-12 ,pp. : 25-30

Springer Publishing Company

Access to resources Recommend Favorite

Sex differences in lipid metabolism and metabolic disease risk

By Sugiyama Michael G.   Agellon Luis B.  

Biochemistry and Cell Biology, Vol. 90, Iss. 2, 2012-04 ,pp. : 124-141

NRC Research Press

Access to resources Recommend Favorite

Novel Developments in Metabolic Disorders of Purine and Pyrimidine Metabolism and Therapeutic Applications of Their Analogs

By Torres Rosa J.   Peters Godefridus J.   Puig Juan G.  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 33, Iss. 4-6, 2014-04 ,pp. : 165-173

Taylor & Francis Ltd

Access to resources Recommend Favorite

Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease

By Karlsson R.-M.   Holmes A.  

Amino Acids, Vol. 31, Iss. 3, 2006-10 ,pp. : 231-239

Springer Publishing Company

Access to resources Recommend Favorite